The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma
Open Access
- 28 October 2011
- journal article
- Published by Elsevier BV in Cell
- Vol. 147 (3), 554-564
- https://doi.org/10.1016/j.cell.2011.09.035
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Constitutive Canonical NF-κB Activation Cooperates with Disruption of BLIMP1 in the Pathogenesis of Activated B Cell-like Diffuse Large Cell LymphomaCancer Cell, 2010
- BLIMP1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-like Diffuse Large B Cell LymphomaCancer Cell, 2010
- Stage-specific sensitivity to p53 restoration during lung cancer progressionNature, 2010
- An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver CancerCell, 2008
- Eph-Ephrin Bidirectional Signaling in Physiology and DiseaseCell, 2008
- Translating insights from the cancer genome into clinical practiceNature, 2008
- Restoration of p53 function leads to tumour regression in vivoNature, 2007
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- Probing tumor phenotypes using stable and regulated synthetic microRNA precursorsNature Genetics, 2005
- Structure of the Semaphorin-3A Receptor Binding ModuleNeuron, 2003